Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism

This week, our guests are Ben Cliff, CEO of UK-based CRO, Concept Life Sciences, and Ravi Rao, chief medical officer of Sitryx.

Interview times

01:12 Sitryx

19:40 CLS

Concept Life Sciences

Concept Life Sciences (CLS), a provider of drug discovery, development, and manufacturing services to the global pharma and biotech sector, recently announced an investment into its drug discovery capabilities.

CLS is the UK’s biggest independent CRO, employing over 250 people, and with a corporate heritage spanning 25 years. Its recent strategic investment in the automation of its ADME (absorption, distribution, metabolism, excretion) which supports clients with me ...